The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. CCXI (“ChemoCentryx”) on behalf of those who purchased or acquired ChemoCentryx common stock between November 26, 2019 and May 6, 2021, inclusive …
Read More




